Explicyte offers a wide range of integrated and highly customizable drug R&D services (in vitro, in vivo and translational research).

Our services range from cell-based assays – for the phenotypic screening of novel immunotherapeutics and the in vitro determination of the molecular mechanism of action of new anti-cancer immune modulators – to in vivo studies, using syngeneic mouse tumor models treated with antitumor immunotherapies. Furthermore, our comprehensive translational research platform spans from stainings to image artificial intelligence-based analysis, and is strongly suited to support digital pathology programs aiming at biomarker and/or novel target evaluation & identification.